Table 4 Top Ten Priorities for Multiple Myeloma Research
1 | How can we cure myeloma? |
2 | Are novel immunotherapies effective for the treatment of myeloma? |
3 | How can we improve the diagnosis (e.g., faster, less invasive) of myeloma, and what is the impact of earlier diagnosis on patient outcomes? |
4 | What are new treatments for myeloma patients that will improve life expectancy with fewer adverse side effects? |
5 | How can we personalize a patient’s treatment based on their type of myeloma and genetic profile, and what is the impact of personalized medicine on treatment efficacy and disease outcomes? |
6 | How can we prevent bone deterioration and/or repair bones that have been damaged without negative side effects or surgery? |
7 | How can we safely reduce, cycle, or stop the use of anti-myeloma medications to reduce the side effects of treatment and maintain control over myeloma? |
8 | How can we reduce or manage the short- and long-term adverse effects of myeloma treatment? |
9 | What is the most effective way (i.e., drug combinations, sequence, frequency, and intensity) to treat refractory, relapsed, and drug resistant myeloma? |
10 | Can we develop treatments specifically for high risk or aggressive myeloma that will improve outcomes for these patients? |